On February 7, the surgical robot "Da Vinci" completed the first robotic cholecystectomy in Hubei Province at Wuhan Union Hospital.
The Da Vinci robot consists of three parts: an ergonomically designed doctor's console; a 4-arm bedside robotic system; and a high-definition 3D video imaging system.
Compared with traditional surgery, Da Vinci robotic surgery has three distinct advantages: it breaks through the limitations of the human eye and magnifies the surgical field of view by 20 times; it breaks through the limitations of human hands and operates in 7 dimensions, which can prevent the possibility of jitter in the human hand; No need to open the abdomen, the wound is only 1 cm, the bleeding is less, the recovery is faster, and the postoperative survival rate and recovery rate are greatly improved.
In addition, the robotic surgery can be enlarged by 4 to 10 times through three-dimensional imaging, and the small blood vessels and fine fibers can be seen clearly, which is convenient for the doctor to make timely judgments. It also has a wide range of uses, reducing the number of surgical staff, saving doctors' physical strength, remote surgery and easy teaching.
After about 1 hour, the patient's gallbladder was successfully removed.
Wang Guobin, the dean of the Concord Hospital and the director of the original gastrointestinal surgery, said: "In the past, only one doctor needed a doctor. The robot operation usually only needs one doctor, which greatly saves the doctor's labor and the doctor can sit. Surgery, a lot easier."
It is reported that the Da Vinci surgical robot is the most advanced robot for surgery in the world. The initial purpose is to explore outer space, provide medical support for astronauts, and provide telemedicine . At present, there are 3,079 surgical robots installed in the world, including 2,153 in the United States and 31 in mainland China.
According to an article published in the British Royal Society journal Interface, an artificial intelligence robot called Eve will help promote the invention of new drugs and make new drugs develop faster. The price is lower. The research team has made a preliminary breakthrough, and "Eve" discovered that an anti-tumor drug may also be used in the treatment of malaria.
"Eve" randomly selects a subset of the compound library to find compounds that pass the first test; these compounds are repeatedly tested repeatedly to reduce the probability of false positive results. "Eve" identifies high-potency compounds that have an effect on selected drug targets. This is a very intelligent, genetically engineered yeast-based screening system that allows Eve to exclude compounds that are toxic to cells and to select compounds that block parasite protein activity without causing damage to human proteins. This process reduces costs and uncertainty and reduces the time required for drug screening, potentially valuable for millions of people around the world.
"Eve" can automatically propose and test hypotheses, run experiments using laboratory robots, then interpret the results to correct the hypothesis, and then repeat the process, automatically completing high-throughput, hypothesis-led research, and its scientific process All aspects can be digitally saved for human research.
Professor Ross King of the University of Manchester Biotechnology Institute said: “Every industry benefits from automation, and science is no exception. Introducing machine learning makes this process intelligent – ​​not just using brute force '- can greatly speed up the speed of scientific development, and may achieve huge returns."
Justin Vail, a urology surgeon at the Royal College of London, believes that robots are now part of everyday medical work. "As robots become cheaper and smaller, they will become routine medical treatments." .
Experts in medical laboratories also predict that the line between humans and robots is very vague. In the future, the subject of the experiment may involve an ingestible or injectable nano-robot that may enable "microscopic" treatment or direct delivery of the drug to the patient's diseased cells. After 30 years, the premise of transplantation will no longer be organ donation, and electronically controlled artificial organs will provide a second life for more and more patients.
On the other hand, the prosthesis will be more convenient for people to use, medical staff will pass important data through sensors, and people's health can be monitored in real time. It is also because of the continuous development and upgrading of technology that Kaspersky has inferred that human life will increase significantly in 2045.
Office Digital Fingerprint Safe
Security Safe,Safe Electrical Box,Commercial Security Safe,Office Digital Fingerprint Safe
Ningbo Reliance Security Technology CO.,Ltd , https://www.reliancesafes.com